GSA Capital Partners’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $252K | Buy |
+132,724
| New | +$252K | 0.02% | 1375 |
|
|
2025
Q1 | – | Sell |
-42,455
| Closed | -$934K | – | 2134 |
|
|
2024
Q4 | $934K | Buy |
42,455
+25,532
| +151% | +$562K | 0.07% | 452 |
|
|
2024
Q3 | $340K | Buy |
+16,923
| New | +$340K | 0.03% | 1163 |
|
|
2024
Q2 | – | Sell |
-10,701
| Closed | -$446K | – | 2080 |
|
|
2024
Q1 | $446K | Sell |
10,701
-20,805
| -66% | -$867K | 0.04% | 955 |
|
|
2023
Q4 | $793K | Buy |
31,506
+10,786
| +52% | +$271K | 0.07% | 516 |
|
|
2023
Q3 | $678K | Buy |
+20,720
| New | +$678K | 0.06% | 609 |
|